[1]许飞?李学军?张强强.中药蛇六谷在胰腺癌治疗中的应用探究[J].陕西中医药大学学报,2022,(01):132-136.[doi:10.13424/j.cnki.jsctcm.2022.01.029]
 XU Fei?LI Xuejun?ZHANG Qiangqiang.Application of Sheliugu in Treatment of Pancreatic Cancer[J].Journal of Shaanxi University of Traditional Chinese Medicine,2022,(01):132-136.[doi:10.13424/j.cnki.jsctcm.2022.01.029]
点击复制

中药蛇六谷在胰腺癌治疗中的应用探究
分享到:

《陕西中医药大学学报》[ISSN:2096-1340/CN:61-1501/R]

卷:
期数:
2022年01期
页码:
132-136
栏目:
综述
出版日期:
2022-02-01

文章信息/Info

Title:
Application of Sheliugu in Treatment of Pancreatic Cancer
文章编号:
2096-1340(2022)01-0132-05
作者:
许飞1?李学军2?张强强1
1.安徽凤阳县人民医院,安徽 凤阳 233100;
2.安徽中医药大学第二附属医院,安徽 合肥 230000
Author(s):
XU Fei1?LI Xuejun2?ZHANG Qiangqiang1
1.Anhui Fengyang County Peoples Hospital,Anhui Fengyang 233100,China;
2.The Second Affiliated Hospital of ???? Anhui University of Traditional Chinese medicine,Hefei 230000,China
关键词:
关键词:蛇六谷中药胰腺癌临床应用探究
Keywords:
Key words: SheliuguTraditional Chinese medicinePancreatic cancerClinical applicationExploration
分类号:
R282.71
DOI:
10.13424/j.cnki.jsctcm.2022.01.029
文献标志码:
A
摘要:
摘 要:胰腺癌是消化系统常见的恶性肿瘤之一,研究发现其发病率、死亡率呈逐年上升的趋势,严重威胁着人们的生命健康,目前西医以放疗、化疗、手术、分子靶向治疗等主要途径,但疗效往往欠理想。反观传统中医药,在治疗胰腺癌上有着独特的优势,临床运用越来越广泛。其中,中药蛇六谷是临床常用的抗肿瘤药材之一,蛇六谷主要通过抑制胰腺癌的肿瘤细胞增殖、诱导细胞凋亡、增强机体细胞免疫等方面达到抗肿瘤的作用,在提高患者生存期的同时,也改善了患者的生活质量,体现了中医药在治疗胰腺癌中的特色与优势,值得临床推广运用。
Abstract:
Abstract: Pancreatic cancer is one of the most common malignant tumors in digestive system.The incidence rate and mortality rate of pancreatic cancer are increasing year by year,which seriously threatens peoples life and health.At present,western medicine is mainly treated by radiotherapy,chemotherapy,surgery and molecular targeted therapy,but its curative effect is not satisfactory.In contrast,traditional Chinese medicine has unique advantages in the treatment of pancreatic cancer,and its clinical application is more and more extensive.Among them,Sheliugu is one of the commonly used antitumor herbs in clinic.Sheliugu plays an important role in inhibiting tumor cell proliferation,inducing apoptosis and enhancing cellular immunity.It improves the survival time of patients and improves the quality of life of patients.It reflects the characteristics and advantages of traditional Chinese medicine in the treatment of pancreatic cancer.It is worthy of clinical application.

参考文献/References:

[1]赵素月,朱克祥,李文军.微生物与胰腺癌致病机制研究进展[J].中国普外基础与临床杂志,2020,27(8):5.
[2]王子晗,马晓璇,孙鹏,等.表观扩散系数在胰腺癌放疗疗效定量评价中的应用[J].基础医学与临床,2020,40(6):817-821.
[3]Zeng H,Chen W,Zheng R,et al.Changing cancer survivalin China during 200315:a pooled analysis of 17 populationbased cancer registries[J].Lancet Global Health,2018,6(5):555-567.
[4]姜菊玲,刘瑞,花宝金.《内经》“杂合以治”在胰腺癌辨治中的应用[J].吉林中医药,2019,39(11):1409-1412.?
[5]吴四智,史玉聪,陈孝银.中医对胰腺癌的认识及中医药干预胰腺癌刍议[J].辽宁中医杂志,2019,46(3):503-505.?
[6]霍文萍,金洪传.晚期胰腺癌内科治疗进展[J].临床荟萃,2020,35(8):761-765.
[7]樊逸夫,张慧卿,陈明骏,等.中医药在胰腺癌多学科综合治疗模式中的应用探究[J].中医药导报,2019,25(15):68-70.
[8]邹温园,戈欣,范小秋,等.蛇六谷抗肿瘤的临床应用与作用机制[J].世界中医药,2019,14(7):1911-1914.
[9]王奇,姜建伟,章红燕.蛇六谷抗肿瘤作用及临床应用研究进展[J].山东中医药大学学报,2016,40(3):291-293.
[10]杨柳,姚静,杨彦坤,等.中药蛇六谷两种药用基原鉴别研究[J].时珍国医国药,2017,28(11):2674-2676.
[11]钱祥,邓德厚,张爱琴,等.大剂量蛇六谷治疗胰腺癌临床体会[J].中医杂志,2015,56(1):7576-82.
[12]邓丹丹,潘立群.蛇六谷在三阴性乳腺癌治疗中的应用[J].中医学报,2018,33(4):541-544.
[13]李赛,潘磊,高瑞兰,等.蛇六谷提取物抑制K562细胞增殖并诱导分化的作用[J].中国病理生理杂志,2019,35(4):592-596.
[14]陈培丰.清热解毒法诱导肿瘤细胞凋亡的研究[J].浙江中医学院学报,2003,27(1):12-15.
[15]常中飞,陈培丰,胡秀敏.蛇六谷提取物抗肿瘤活性筛选及初步化学成分分析[J].时珍国医国药,2012,23(3):580-581.
[16]何亚娟,李久香,原俊.魔芋对艾氏腹水瘤(EAC)抑制作用的研究[J].肿瘤防治研究,2000,28(3):197-198,200.
[17]Freddy,Radtke,Kenneth,et al.The role of Notch in tumorigenesis:oncogene or tumour suppressor?[J].Nature Reviews Cancer,2003,3(10):756-767.
[18]Mullendore ME,Koorstra JB,Li YM,et al.Liganddependent Notch signaling is involved in tumor initiation andtumor maintenance in pancreatic cancer[J].Clinicla Cancer Research,2009,15(7):2291-2301.
[19]Iso T,Kedes L,Hamamori Y.HES and HERP families:multiple effectors of the Notch signaling pathway[J].Journal of Cellular Physiology,2003,194(3):237-255.
[20]邹温园,戈欣,范小秋,等.蛇六谷抗肿瘤的临床应用与作用机制[J].世界中医药,2019,14(7):1911-1914.?
[21]刘鲁明.中西医结合治疗胰腺癌的机遇与挑战[J].中国中西医结合杂志,2019,39(1):18-20.
[22]王奇,章红燕,姜志明.蛇六谷乙烯醇提取物对小鼠血细胞的毒性的初步研究[J].中国中西医结合消化杂志,2016,24(7):512-514.
[23]杨柳,倪艳,姚静,等.蛇六谷的基原考证、抗肿瘤作用及临床应用研究进展[J].中国药房,2016,27(34):4876-4879.
[24]韩俊,谢安卫,刘利红.清胰化积汤联合动脉灌注化疗治疗中晚期胰腺癌[J].中医学报,2018,33(7):1165-1169.?
[25]夏宁俊,王国方,田永立.胰腺癌常用中医治法探讨[J].中医学报,2018,33(1):30-33.
[26]夏淑敏,马科,林莹,等.马科运用扶正祛邪法治疗胰腺癌经验[J].湖南中医杂志,2019,35(12):26-27.
[27]张稚淳,贾梦冉,田劭丹,等.李佩文教授治疗胰腺癌经验探讨[J].天津中医药,2019,36(12):1160-1162.
[28]孙润菲,孙明瑜.国医大师刘嘉湘治疗胰腺癌学术经验[J].辽宁中医杂志,2020,47(4):33-36.
[29]吴超勇,王苗苗,张培彤,等.张培彤治疗胰腺癌的临床用药规律[J].中医学报,2019,34(9):1889-1892.
[30]肖雅瑜,曾普华,郜文辉,等.曾普华教授辨治胰腺癌特色探析[J].陕西中医,2020,41(5):667-669,681.
[31]王卫国,黎斌怡.蒋士卿教授调理脾胃治疗胰腺癌经验[J].中医研究,2020,33(2):37-39.
[32]钱祥,邓德厚,张爱琴,等.大剂量蛇六谷治疗胰腺癌临床体会[J].中医杂志,2015,56(1):75-76,82.
[33]李雪松,袁素.张士舜教授治疗肿瘤标志物增高经验[J].中医学报,2017,32(11):2058-2059.
[34]王振东,唐建荣,李大威.清胰化积方对中晚期胰腺癌患者生存期及细胞免疫功能的影响[J].世界中西医结合杂志,2018,13(7):984-988.
[35]朱才琴,丁尧光,刘嘉湘.刘嘉湘中医药治疗胰腺癌心得体会[J].内蒙古中医药,2013,32(33):41-42.
[36]费园,祁琪,刘鲁明.刘鲁明教授清胰化积方加味治疗中晚期胆囊癌经验[J].内蒙古中医药,2018,37(1):1-3.
[37]沈晔华,刘鲁明,孟志强,等.清胰化积方为主综合治疗晚期胰腺癌64例生存分析[J].中医杂志,2009,50(1):39-42.

相似文献/References:

[1]林依娜.中药治疗慢性萎缩性胃炎临床疗效的 Meta分析[J].陕西中医药大学学报,2018,(04):052.[doi:10.13424/j.cnki.jsctcm.2018.04.016]
 Lin Yina.Meta Analysis of Clinical Effect of Chinese Medicine in Treating Chronic Atrophic Gastritis[J].Journal of Shaanxi University of Traditional Chinese Medicine,2018,(01):052.[doi:10.13424/j.cnki.jsctcm.2018.04.016]
[2]张颖 李崇慧.国医大师徐经世运用中医药治疗肝癌经验拾萃[J].陕西中医药大学学报,2018,(05):022.[doi:DOI:10.13424/j.cnki.jsctcm.2018.05.007]
[3]杨剑 张永刚.自拟清热利湿饮配合针灸治疗带状疱疹临床研究[J].陕西中医药大学学报,2018,(05):077.[doi:DOI:10.13424/j.cnki.jsctcm.2018.05.024]
[4]朋汤义 刘勇 郭锦晨 司雨 冯烨.中药的望闻问切[J].陕西中医药大学学报,2018,(05):178.[doi:DOI:10.13424/j.cnki.jsctcm.2018.05.052]
[5]杨 杰,姜小艳,李 健.理肠汤结合溃疡灵灌肠治疗脾虚湿困型溃疡性结肠炎40例[J].陕西中医药大学学报,2019,(03):108.[doi:10.13424/j.cnki.jsctcm.2019.03.028]
[6]付书 孙宇洁 李慧 朋汤义.基于中药“望闻问切”理论探析取象比类思维下的中药形状与药效[J].陕西中医药大学学报,2020,(5):057.[doi:10.13424/j.cnki.jsctcm.2020.05.015]
[7]杨兴,王泽,李佳,等.纯天然植物洗洁精的制备[J].陕西中医药大学学报,2020,(6):059.[doi:10.13424/j.cnki.jsctcm.2020.06.013]
[8]李园 程悦 朋汤义.浅析影响中药临床疗效的因素及应对措施[J].陕西中医药大学学报,2021,44(05):054.[doi:10.13424/j.cnki.jsctcm.2021.05.011]
[9]尹硕淼 高志凌 聂卫群.虫类药在肺系疾病中的应用探析[J].陕西中医药大学学报,2021,44(05):059.[doi:10.13424/j.cnki.jsctcm.2021.05.012]
[10]李江 徐斌 乔治 谭龙旺.强脊方对强直性脊柱炎患者Th17细胞及相关因子IL-6、IL-23影响的临床研究[J].陕西中医药大学学报,2022,(01):088.[doi:10.13424/j.cnki.jsctcm.2022.01.019]
 LI Jiang XU BinQIAO Zhi TAN Longwang.Clinical Study on The Effect of Qiangji Recipe on Th17 Cells and Related Factors IL-6 and IL-23 in Patients with Ankylosing Spondylitis[J].Journal of Shaanxi University of Traditional Chinese Medicine,2022,(01):088.[doi:10.13424/j.cnki.jsctcm.2022.01.019]

更新日期/Last Update: 2022-02-10